Concepedia

Jennifer L. Tabor-Rennie

JL

Statistics

Publications

3

Citations

81

H-Index

3

Active since

2019

Affiliations

Hartford Hospital(Current)

Hartford Financial Services (United States)

Jennifer L. Tabor-Rennie is an author at Hartford Hospital specializing in antimicrobial pharmacotherapy, pharmacology, and microbiology.

Publications per year

2019–2022

3

Publications

3

<i>In Vivo</i> Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in the Neutropenic Murine Thigh Infection Model

Marguerite L. Monogue, Jennifer L. Tabor-Rennie, Kamilia Abdelraouf et al. · Antimicrobial Agents and Chemotherapy · 2019 · 35 citations · Full text

, , +11

Trimethoprim/sulfamethoxazole pharmacodynamics against <i>Stenotrophomonas maltophilia</i> in the <i>in vitro</i> chemostat model

Maxwell J. Lasko, Jennifer L. Tabor-Rennie, Joseph L. Kuti · Journal of Antimicrobial Chemotherapy · 2022 · 24 citations

, , +9

<i>In Vitro</i> Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth

Maxwell J. Lasko, Matthew Gethers, Jennifer L. Tabor-Rennie et al. · Antimicrobial Agents and Chemotherapy · 2022 · 22 citations · Full text

, , +17

1–3 of 3